Stroke is a leading cause of
death and disability globally.

We're on a mission to change that.

Mission Thrombectomy: Global Access for Stroke Treatment's mission is to accelerate global access for stroke treatment and care globally and increase public awareness of stroke symptoms. Mechanical Thrombectomy is an extremely effective standard-of-care procedure for large vessel occlusions or strokes caused by a blockage in the brain.

This intervention can prevent, and in many cases reverse, the terrible effects of this type of stroke in over 60% of patients if done by experts within 6-24 hours of stroke symptoms. However, as of today, less than 3% of stroke victims across the globe have access to this life saving treatment.

Read More

Did You Know?

As of 2022 there are 7.8 billion people in the world! Of those...
people in a circle

12.2 million people will have a stroke.

clot

10.6 million of those strokes will be an ischemic stroke (strokes that are caused by a clot).

mission thrombectomy brain
Only about 318,000, or <3% of those ischemic strokes will be treated with mechanical thrombectomy.

You Can Help.

1 in 4 people will have a stroke in their lifetime, but not everyone has equal access to treatment.

Across the globe, only about 3% of eligible stroke patients can access stroke thrombectomy. There are 3 primary reasons why this life saving treatment isn’t available: low per capita gross national income (an indicator that access to care is limited), local Large Vessel Occlusion (LVO) triage policies, and the lack of mechanical thrombectomy trained operators and/or centers
available.

As an advocacy committee of the Society of Vascular and Interventional Neurology (SVIN), a 501c3 non-profit whose mission is to advance the fields of vascular and interventional neurosciences to improve patient outcomes, Mission Thrombectomy is here to change this.

When you donate to SVIN Mission Thrombectomy, you are helping bring stroke treatment to your neighbor, friend, or family member, no matter where they live. Together, we can close the gap by funding research, education, and advocacy campaigns to speed up the timeline of bringing treatment innovation to every country around the world.

CLOSE THE GAP